HealthEquity SG&A Expenses 2014-2024 | HQY
HealthEquity annual/quarterly sg&a expenses history and growth rate from 2014 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- HealthEquity sg&a expenses for the quarter ending July 31, 2024 were $0.054B, a 14.56% increase year-over-year.
- HealthEquity sg&a expenses for the twelve months ending July 31, 2024 were $0.206B, a 16.61% increase year-over-year.
- HealthEquity annual sg&a expenses for 2024 were $0.183B, a 9.99% increase from 2023.
- HealthEquity annual sg&a expenses for 2023 were $0.166B, a 15.47% increase from 2022.
- HealthEquity annual sg&a expenses for 2022 were $0.144B, a 7.13% increase from 2021.
| HealthEquity Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $183 |
| 2023 | $166 |
| 2022 | $144 |
| 2021 | $134 |
| 2020 | $105 |
| 2019 | $63 |
| 2018 | $48 |
| 2017 | $38 |
| 2016 | $27 |
| 2015 | $19 |
| 2014 | $12 |
| 2013 | $11 |
| HealthEquity Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-07-31 | $54 |
| 2024-04-30 | $62 |
| 2024-01-31 | $44 |
| 2023-10-31 | $46 |
| 2023-07-31 | $47 |
| 2023-04-30 | $45 |
| 2023-01-31 | $42 |
| 2022-10-31 | $42 |
| 2022-07-31 | $42 |
| 2022-04-30 | $40 |
| 2022-01-31 | $38 |
| 2021-10-31 | $33 |
| 2021-07-31 | $38 |
| 2021-04-30 | $35 |
| 2021-01-31 | $36 |
| 2020-10-31 | $35 |
| 2020-07-31 | $33 |
| 2020-04-30 | $30 |
| 2020-01-31 | $37 |
| 2019-10-31 | $32 |
| 2019-07-31 | $18 |
| 2019-04-30 | $18 |
| 2019-01-31 | $16 |
| 2018-10-31 | $17 |
| 2018-07-31 | $15 |
| 2018-04-30 | $14 |
| 2018-01-31 | $14 |
| 2017-10-31 | $12 |
| 2017-07-31 | $11 |
| 2017-04-30 | $10 |
| 2017-01-31 | $10 |
| 2016-10-31 | $10 |
| 2016-07-31 | $10 |
| 2016-04-30 | $9 |
| 2016-01-31 | $8 |
| 2015-10-31 | $7 |
| 2015-07-31 | $7 |
| 2015-04-30 | $6 |
| 2015-01-31 | $7 |
| 2014-10-31 | $5 |
| 2014-07-31 | $4 |
| 2014-04-30 | $3 |
| 2014-01-31 | |
| 2013-10-31 | $3 |
| 2013-07-31 | $3 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.966B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $91.424B | 11.34 |
| Cencora (COR) | United States | $47.484B | 17.51 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| Natera (NTRA) | United States | $21.401B | 0.00 |
| ICON (ICLR) | Ireland | $16.136B | 14.37 |
| Viatris (VTRS) | United States | $15.576B | 4.80 |
| Avantor (AVTR) | United States | $13.422B | 20.12 |
| Revvity (RVTY) | United States | $13.376B | 23.24 |
| CochLear (CHEOY) | Australia | $12.844B | 0.00 |
| BioMerieux (BMXMF) | France | $12.666B | 0.00 |
| Solventum (SOLV) | United States | $11.583B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.789B | 27.58 |
| Doximity (DOCS) | United States | $9.620B | 56.63 |
| Charles River Laboratories (CRL) | United States | $9.516B | 18.39 |
| Sonic Healthcare (SKHHY) | Australia | $8.758B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.885B | 32.05 |
| Life Times (LTH) | United States | $5.085B | 33.66 |
| Sotera Health (SHC) | United States | $3.855B | 20.62 |
| Organon (OGN) | United States | $3.757B | 3.79 |
| BrightSpring Health Services (BTSG) | United States | $3.247B | 69.07 |
| Surgery Partners (SGRY) | United States | $2.892B | 32.97 |
| PACS (PACS) | United States | $2.606B | 0.00 |
| Concentras Parent (CON) | United States | $2.581B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.375B | 0.00 |
| Premier (PINC) | United States | $2.143B | 11.15 |
| Alignment Healthcare (ALHC) | United States | $2.126B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.952B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.616B | 42.40 |
| Teladoc Health (TDOC) | United States | $1.537B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.255B | 12.28 |
| CareDx (CDNA) | United States | $1.183B | 0.00 |
| Progyny (PGNY) | United States | $1.164B | 23.57 |
| Establishment Labs Holdings (ESTA) | $1.050B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.954B | 6.46 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Embecta (EMBC) | United States | $0.778B | 5.18 |
| SBC Medicals (SBC) | United States | $0.677B | 0.00 |
| Agilon Health (AGL) | United States | $0.655B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.647B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.536B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.425B | 0.00 |
| DocGo (DCGO) | United States | $0.410B | 15.46 |
| Enhabit (EHAB) | United States | $0.366B | 31.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.326B | 0.00 |
| LifeMD (LFMD) | United States | $0.241B | 0.00 |
| ModivCare (MODV) | United States | $0.223B | 12.09 |
| Sera Prognostics (SERA) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Biodesix (BDSX) | United States | $0.180B | 0.00 |
| Nutex Health (NUTX) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.100B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.25 |
| MultiPlan (MPLN) | United States | $0.084B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.043B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.08 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.020B | 0.00 |
| Oncology Institute (TOI) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |